LEXICON PHARMACEUTICALS, INC. - Common Stock, par value $0.001 per share (LXRX)

CUSIP: 528872302

Q1 2019 13F Holders as of 31 Mar 2019

Type / Class
Equity / Common Stock, par value $0.001 per share
Shares outstanding
444,558,533
Total 13F shares
104,271,703
Share change
-884,941
Total reported value
$579,706,451
Put/Call ratio
417%
Price per share
$5.56
Number of holders
112
Value change
-$6,638,791
Number of buys
51
Number of sells
49

Security key

528872302

Report period

Q1 2019

Institutions

112

Top holders

10

Top shareholders of LXRX - LEXICON PHARMACEUTICALS, INC. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
Artal Group S.A.
13F
Company
14%
60,240,864
$400,000,000 31 Dec 2018
13F
FMR LLC
13F
Company
3.3%
14,739,614
$97,871,000 31 Dec 2018
13F
BlackRock Finance, Inc.
13F
Company
0.98%
4,356,726
$28,928,000 31 Dec 2018
13F
Ulys, L.L.C.
13F
Individual
0.97%
4,321,214
$28,693,000 31 Dec 2018
13F
VANGUARD GROUP INC
13F
Company
0.67%
2,985,162
$19,821,000 31 Dec 2018
13F
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
13F
Company
0.66%
2,942,423
$19,537,688 31 Dec 2018
13F
NEA Management Company, LLC
13F
Company
0.54%
2,382,286
$15,818,000 31 Dec 2018
13F
STATE STREET CORP
13F
Company
0.42%
1,846,498
$12,261,000 31 Dec 2018
13F
Clearbridge Investments, LLC
13F
Company
0.28%
1,249,590
$8,297,000 31 Dec 2018
13F
Gamma As Sector
13F
Individual
0.19%
862,602
$5,728,000 31 Dec 2018
13F
NORTHERN TRUST CORP
13F
Company
0.14%
605,764
$4,024,000 31 Dec 2018
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
0.13%
565,085
$3,752,000 31 Dec 2018
13F
PINNACLE ASSOCIATES LTD
13F
Company
0.12%
540,934
$3,592,000 31 Dec 2018
13F
S.c.a. Candriam
13F
Individual
0.11%
509,000
$3,380,000 31 Dec 2018
13F
PICTET ASSET MANAGEMENT LTD
13F
Company
0.09%
411,450
$2,732,000 31 Dec 2018
13F
CITIGROUP INC
13F
Company
0.09%
397,644
$2,641,000 31 Dec 2018
13F
RENAISSANCE TECHNOLOGIES LLC
13F
Company
0.08%
344,486
$2,287,000 31 Dec 2018
13F
CITADEL ADVISORS LLC
13F
Company
0.08%
335,822
$2,230,000 31 Dec 2018
13F
TEACHERS RETIREMENT SYSTEM OF THE STATE OF KENTUCKY
13F
Company
0.07%
321,156
$2,132,000 31 Dec 2018
13F
TWO SIGMA INVESTMENTS, LP
13F
Company
0.07%
313,877
$2,084,000 31 Dec 2018
13F
DEUTSCHE BANK AG\
13F
Company
0.07%
295,619
$1,962,000 31 Dec 2018
13F
D. E. Shaw & Co., Inc.
13F
Company
0.06%
268,476
$1,783,000 31 Dec 2018
13F
MARSHALL WACE, LLP
13F
Company
0.06%
264,139
$1,754,000 31 Dec 2018
13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC
13F
Company
0.06%
259,501
$1,724,000 31 Dec 2018
13F
JACOBS LEVY EQUITY MANAGEMENT, INC
13F
Company
0.06%
247,090
$1,641,000 31 Dec 2018
13F
Bank of New York Mellon Corp
13F
Company
0.04%
187,403
$1,244,000 31 Dec 2018
13F
UBS Group AG
13F
Company
0.04%
177,886
$1,181,000 31 Dec 2018
13F
WEDBUSH SECURITIES INC
13F
Company
0.04%
174,442
$1,158,000 31 Dec 2018
13F
PDT Partners, LLC
13F
Company
0.03%
154,501
$1,026,000 31 Dec 2018
13F
NORGES BANK
13F
Company
0.03%
151,347
$1,005,000 31 Dec 2018
13F
HAP Trading, LLC
13F
Company
0.03%
143,537
$953,000 31 Dec 2018
13F
MORGAN STANLEY
13F
Company
0.03%
140,787
$935,000 31 Dec 2018
13F
TIAA CREF INVESTMENT MANAGEMENT LLC
13F
Company
0.03%
137,267
$911,000 31 Dec 2018
13F
STIFEL FINANCIAL CORP
13F
Company
0.02%
106,345
$705,000 31 Dec 2018
13F
GOLDMAN SACHS GROUP INC
13F
Company
0.02%
105,093
$698,000 31 Dec 2018
13F
Fosun International Ltd
13F
Company
0.02%
100,621
$639,000 31 Dec 2018
13F
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM
13F
Company
0.02%
99,456
$660,000 31 Dec 2018
13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP
13F
Company
0.02%
97,478
$647,000 31 Dec 2018
13F
MILLENNIUM MANAGEMENT LLC
13F
Company
0.02%
95,169
$632,000 31 Dec 2018
13F
ALLIANCEBERNSTEIN L.P.
13F
Company
0.02%
89,303
$593,000 31 Dec 2018
13F
ROYAL LONDON ASSET MANAGEMENT LTD
13F
Company
0.02%
84,918
$563,000 31 Dec 2018
13F
TEACHERS ADVISORS, LLC
13F
Company
0.02%
82,915
$551,000 31 Dec 2018
13F
Deutsche Girozentrale DekaBank
13F
Individual
0.02%
82,419
$528,000 31 Dec 2018
13F
VIRTUS ADVISERS, LLC
13F
Company
0.02%
82,295
$546,000 31 Dec 2018
13F
Swiss National Bank
13F
Company
0.02%
74,914
$497,000 31 Dec 2018
13F
Tekla Capital Management LLC
13F
Company
0.02%
70,000
$465,000 31 Dec 2018
13F
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM
13F
Company
0.02%
67,634
$449,000 31 Dec 2018
13F
SIMPLEX TRADING, LLC
13F
Company
0.01%
58,586
$389,000 31 Dec 2018
13F
RHUMBLINE ADVISERS
13F
Company
0.01%
57,193
$380,000 31 Dec 2018
13F
GSA CAPITAL PARTNERS LLP
13F
Company
0.01%
56,586
$376,000 31 Dec 2018
13F

Institutional Holders of LEXICON PHARMACEUTICALS, INC. - Common Stock, par value $0.001 per share (LXRX) as of Q1 2019

As of 31 Mar 2019, LEXICON PHARMACEUTICALS, INC. - Common Stock, par value $0.001 per share (LXRX) was held by 112 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 104,271,703 shares. The largest 10 holders included Artal Group S.A., FMR LLC, Ulys, L.L.C., BlackRock Inc., VANGUARD GROUP INC, FIRST MANHATTAN CO, NEA Management Company, LLC, Clearbridge Investments, LLC, UBS ASSET MANAGEMENT AMERICAS INC, and STATE STREET CORP. This page lists 112 institutional shareholders reporting positions in this security for the Q1 2019 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q1 2019 vs Q4 2018 Across Filers

Q4 2018 holders
117
Q1 2019 holders
112
Holder diff
-5
Investor Q4 2018 Shares Q1 2019 Shares Share Diff Share Chg % Q4 2018 Value $ Q1 2019 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .